The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices
Open accessAbstract
Cervical cancer (CC) represents the fourth most common malignancy affecting women all over the world and is the second most common in developing areas. In these areas, the burden from disease remains important because of the difficulty in implementing cytology-based screening programmes. The main obstacles inherent to these countries are poverty and a lack of healthcare infrastructures and trained practitioners. With the availability of new technologies, researchers have attempted to find new strategies that are adapted to low- and middle-income countries (LMIC) to promote early diagnosis of cervical pathology. Current evidence suggests that human papillomavirus (HPV) testing is more effective than cytology for CC screening. Therefore, highly sensitive tests have now been developed for primary screening. Rapid molecular methods for detecting HPV DNA have only recently been commercially available. This constitutes a milestone in CC screening in low-resource settings because it may help overcome the great majority of obstacles inherent to previous screening programmes. Despite several advantages, HPV-based screening has a low positive predictive value for CC, so that HPV-positive women need to be triaged with further testing to determine optimal management. Visual inspection tests, cytology and novel biomarkers are some options. In this review, we provide an overview of current and emerging screening approaches for CC. In particular, we discuss the challenge of implementing an efficient cervical screening adapted to LMIC and the opportunity to introduce primary HPV-based screening with the availability of point-of-care (POC) HPV testing. The most adapted screening strategy to LMIC is still a work in progress, but we have reasons to believe that POC HPV testing makes part of the future strategies in association with a triage test that still needs to be defined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Correspondence - Tranexamic acid for traumatic brain injury
(2005) · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) · doi:10.1016/s0140-6736 · Cited by 11,894
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,321
Cuzick, J., Clavel, C., Petry, K., Meijer, C. J. L. M., Hoyer, H., Ratnam, S., Szarewski, A., Birembaut, P., Kulasingam, S., Sasieni, P., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21955 · Cited by 1,141
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand, M.-H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,100
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles
Bastani, R., Glenn, B. A., & Maxwell, A. E. (2015) · eCite Digital Repository (University of Tasmania) · doi:10.1158/1055-9965 · Cited by 901
Effective screening programmes for cervical cancer in low- and middle-income developing countries.
(2001) · Europe PMC (PubMed Central) · Cited by 724
Meijer, C. J. L. M., Berkhof, J., Castle, P. E., Hesselink, A. T., Franco, E. L., Ronco, G., Arbyn, M., Bosch, F. X., Cuzick, J., Dillner, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24010 · Cited by 692
Sankaranarayanan, R., Esmy, P. O., Rajkumar, R., Muwonge, R., Swaminathan, R., Shanthakumari, S., Fayette, J.-M., & Cherian, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61195-7 · Cited by 540
Castle, P. E., Stoler, M. H., Wright, T. C., Sharma, A., Wright, T. L., & Behrens, C. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70188-7 · Cited by 523
Cervical cancer screening: who is not screened and why?
Harlan, L. C., Bernstein, A. B., & Kessler, L. G. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.7.885 · Cited by 480
HPV‐mediated cervical carcinogenesis: concepts and clinical implications
Snijders, P. J., Steenbergen, R. D., Heideman, D. A., & Meijer, C. J. (2006) · The Journal of Pathology · doi:10.1002/path.1866 · Cited by 455
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Steenbergen, R. D. M., Snijders, P. J. F., Heideman, D. A. M., & Meijer, C. J. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3728 · Cited by 386
Chapter 8: Screening for cervical cancer in developing countries
Denny, L., Quinn, M., & Sankaranarayanan, R. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.121 · Cited by 354
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells
Martinez, I., Gardiner, A. S., Board, K. F., Monzon, F. A., Edwards, R. P., & Khan, S. A. (2008) · Oncogene · doi:10.1038/sj.onc.1210919 · Cited by 340
Goldie, S. J., Kuhn, L., Denny, L., Pollack, A., & Wright, T. C. (2001) · JAMA · doi:10.1001/jama.285.24.3107 · Cited by 335
Cyclooxygenase-2 is overexpressed in human cervical cancer.
Kulkarni, S., Rader, J. S., Zhang, F., Liapis, H., Koki, A. T., Masferrer, J. L., Subbaramaiah, K., & Dannenberg, A. J. (2001) · PubMed · Cited by 328
Tsoumpou, I., Arbyn, M., Kyrgiou, M., Wentzensen, N., Koliopoulos, G., Martin-Hirsch, P., Malamou-Mitsi, V., & Paraskevaidis, E. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.10.005 · Cited by 323
Oncogenic activities of human papillomaviruses
McLaughlin-Drubin, M. E., & Münger, K. (2009) · Virus Research · doi:10.1016/j.virusres.2009.06.008 · Cited by 321
Sankaranarayanan, R., Basu, P., Wesley, R. S., Mahe, C., Keita, N., Mbalawa, C. C. G., Sharma, R., Dolo, A., Shastri, S. S., Nacoulma, M., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20190 · Cited by 319
Arbyn, M., Sankaranarayanan, R., Muwonge, R., Keita, N., Dolo, A., Mbalawa, C. G., Nouhou, H., Sakande, B., Wesley, R., Somanathan, T., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23489 · Cited by 311
A MicroRNA Expression Signature for Cervical Cancer Prognosis
Hu, X., Schwarz, J. K., Lewis, J. S., Huettner, P. C., Rader, J. S., Deasy, J. O., Grigsby, P. W., & Wang, X. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3289 · Cited by 310
Altered MicroRNA Expression in Cervical Carcinomas
Lee, J.-W., Choi, C. H., Choi, J.-J., Park, Y.-A., Kim, S.-J., Hwang, S. Y., Kim, W. Y., Kim, T.-J., Lee, J.-H., Kim, B.-G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1231 · Cited by 309
A critical assessment of screening methods for cervical neoplasia
Sankaranarayanan, R., Gaffikin, L., Jacob, M., Sellors, J., & Robles, S. (2005) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2005.01.009 · Cited by 308
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Gillio-Tos, A., Minucci, D., Naldoni, C., Rizzolo, R., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn065 · Cited by 306
Petignat, P., Faltin, D. L., Bruchim, I., Tramèr, M. R., Franco, E. L., & Coutlée, F. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.01.023 · Cited by 290
McLaughlin-Drubin, M. E., Crum, C. P., & Münger, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009933108 · Cited by 288
Cuschieri, K., & Wentzensen, N. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0306 · Cited by 273
LaMontagne, D. S., Barge, S., Le, N. T., Mugisha, E., Penny, M., Gandhi, S., Janmohamed, A., Kumakech, E., Mosqueira, N. R., Nguyen, N. Q., et al. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.08986 · Cited by 271
Snijders, P. J. F., Verhoef, V. M. J., Arbyn, M., Ogilvie, G., Minozzi, S., Banzi, R., van Kemenade, F. J., Heideman, D. A. M., & Meijer, C. J. L. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.27790 · Cited by 265
Leinonen, M., Nieminen, P., Kotaniemi-Talonen, L., Malila, N., Tarkkanen, J., Laurila, P., & Anttila, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp367 · Cited by 259
Lajer, C. B., Garnæs, E., Friis-Hansen, L., Norrild, B., Therkildsen, M. H., Glud, M., Rossing, M., Lajer, H., Svane, D., Skotte, L., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.109 · Cited by 256
The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer
Fernandez, A. F., Rosales, C., Lopez-Nieva, P., Graña, O., Ballestar, E., Ropero, S., Espada, J., Melo, S. A., Lujambio, A., Fraga, M. F., et al. (2009) · Genome Research · doi:10.1101/gr.083550.108 · Cited by 255
Evaluation of alternative methods of cervical cancer screening for resource-poor settings
Denny, L., Kuhn, L., Pollack, A., Wainwright, H., & Wright, T. C. (2000) · Cancer · doi:10.1002/1097-0142(20000815)89:4<826::aid-cncr15>3.0.co;2-5 · Cited by 253
Accuracy of visual inspection with acetic acid for cervical cancer screening
Sauvaget, C., Fayette, J., Muwonge, R., Wesley, R., & Sankaranarayanan, R. (2011) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.10.012 · Cited by 245
Lazcano-Ponce, E., Lorincz, A. T., Cruz-Valdez, A., Salmerón, J., Uribe, P., Velasco-Mondragón, E., Nevarez, P. H., Acosta, R. D., & Hernández-Avila, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61522-5 · Cited by 230
Dzuba, I. G., Díaz, E. Y., Allen, B., Leonard, Y. F., Lazcano Ponce, E. C., Shah, K. V., Bishai, D., Lorincz, A., Ferris, D., Turnbull, B., et al. (2002) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460902753668466 · Cited by 208
Cervical cancer: Biomarkers for diagnosis and treatment
Dasari, S., Wudayagiri, R., & Valluru, L. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.03.005 · Cited by 200
MicroRNA Expression Variability in Human Cervical Tissues
Pereira, P. M., Marques, J. P., Soares, A. R., Carreto, L., & Santos, M. A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011780 · Cited by 186
Ogilvie, G. S. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2004.011858 · Cited by 182
The Accuracy of Colposcopic Grading for Detection of High-Grade Cervical Intraepithelial Neoplasia
Massad, L. S., Jerónimo, J., Katki, H. A., & SCHIFFMAN, M. H. (2009) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31819308d4 · Cited by 174
Arbyn, M., Rebolj, M., De Kok, I. M. C. M., Fender, M., Becker, N., O’Reilly, M., & Andrae, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.016 · Cited by 167
Trappen, P. O. V., Steele, D., Lowe, D. G., Baithun, S. I., Beasley, N. J. P., Thiele, W., Weich, H. A., Krishnan, J., Shepherd, J. H., Pepper, M. S., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1467 · Cited by 156
Monsonégo, J., Hudgens, M. G., Zerat, L., Zerat, J., Syrjänen, K. J., Halfon, P., Ruiz, F., & Smith, J. S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25726 · Cited by 151
Melar-New, M., & Laimins, L. A. (2010) · Journal of Virology · doi:10.1128/jvi.00078-10 · Cited by 145
(2012) · PubMed Central · Cited by 139
Blumenthal, P. D., Gaffikin, L., Deganus, S., Lewis, R., Emerson, M. R., & Adadevoh, S. W. K. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.12.031 · Cited by 135
Cancer Prevention in Primary Care: Screening for cervical cancer
Austoker, J. (1994) · BMJ · doi:10.1136/bmj.309.6949.241 · Cited by 128
Dockter, J., Schröder, A., Hill, C. S., Guzenski, L., Monsonégo, J., & Giachetti, C. (2009) · Journal of Clinical Virology · doi:10.1016/s1386-6532(09)70009-5 · Cited by 118
Sankaranarayanan, R., Anorlu, R. I., Sangwa‐Lugoma, G., & Denny, L. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.06.066 · Cited by 110
Gravitt, P. E., Belinson, J. L., Salmeron, J., & Shah, K. V. (2011) · International Journal of Cancer · doi:10.1002/ijc.25974 · Cited by 106
Alternative approaches to cervical cancer screening for developing countries
Wright, T. C., & Kuhn, L. (2012) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.11.004 · Cited by 105
Deftereos, G., Corrie, S. R., Feng, Q., Morihara, J. K., Stern, J., Hawes, S. E., & Kiviat, N. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028423 · Cited by 105
Suprynowicz, F. A., Disbrow, G. L., Krawczyk, E., Simić, V., Lantzky, K., & Schlegel, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210725 · Cited by 94
Lower cost strategies for triage of human papillomavirus DNA‐positive women
Qiao, Y., Jerónimo, J., Zhao, F., Schweizer, J., Chen, W., Valdez, M., Lu, P. S., Zhang, X., Kang, L., Bansil, P., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28616 · Cited by 90
Factors Affecting Uptake of Cervical Cancer Early Detection Measures Among Women in Thika, Kenya
Ngugi, C. W., Boga, H. I., Muigai, A. W. T., Wanzala, P., & Mbithi, J. (2012) · Health Care For Women International · doi:10.1080/07399332.2011.646367 · Cited by 84
Bigoni, J., Gundar, M., Tebeu, P. M., Bongoe, A., Schäfer, S. S., Domgue, J. F., Catarino, R., Tincho, E., Bougel, S., Vassilakos, P., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29353 · Cited by 77
Self-citationCervical cancer screening: which HPV test should be used—L1 or E6/E7?
Tjalma, W. A. A., & Depuydt, C. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.06.027 · Cited by 72
Tumor Antigens CA 19.9, CA 125, and CEA in Carcinoma of the Uterine Cervix
Borras, G., Molina, R., Xercavins, J., Ballesta, A. M., & Iglesias, J. M. R. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1126 · Cited by 70
Sancho-Garnier, H., Khazraji, Y. C., Cherif, M. H., Mahnane, A., Hsaïri, M., Shalakamy, A. E., Osgul, N., Tuncer, M. A., Jumaan, A. O., & Seoud, M. A.-F. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.06.046 · Cited by 69
Shi, J., Canfell, K., Lew, J., Zhao, F., Legood, R., Ning, Y., Simonella, L., Ma, L., Kang, Y., Zhang, Y., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-239 · Cited by 68
Women's participation in a cervical cancer screening program in northern Peru
Winkler, J. L., Bingham, A., Coffey, P. S., & Handwerker, W. P. (2007) · Health Education Research · doi:10.1093/her/cyl156 · Cited by 67
Cervical cancer screening with naked-eye visual inspection in Colombia
Murillo, R., Luna, J., Gamboa, Ó., Osorio, E., Bonilla, J., & Cendales, R. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.01.019 · Cited by 60
Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
Han, Y., Xu, G., Lu, H., Yu, D.-H., Ren, Y., Wang, L., Huang, X.-H., Hou, W., Wei, Z., Chen, Y.-P., et al. (2015) · Europe PMC (PubMed Central) · Cited by 56
Different cervical cancer screening approaches in a Chinese multicentre study
Li, N., Shi, J.-F., Franceschi, S., Zhang, W.-H., Dai, M., Liu, B., Zhang, Y.-Z., Li, L.-K., Wu, R.-F., Vuyst, H. D., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604840 · Cited by 49
Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer
Tjalma, W. A. A., Arbyn, M., Paavonen, J. A., Waes, T. R. V., & Bogers, J. (2004) · International Journal of Gynecological Cancer · doi:10.1111/j.1048-891x.2004.014505.x · Cited by 49
Untiet, S., Vassilakos, P., McCarey, C., Tebeu, P. M., Fosso, G. K., Menoud, P.-A., Boulvain, M., Navarria, I., & Petignat, P. (2014) · International Journal of Cancer · doi:10.1002/ijc.28834 · Cited by 48
Muwonge, R., Wesley, R. S., Nene, B. M., Shastri, S. S., Jayant, K., Malvi, S. G., Somanathan, T., & Sankaranarayanan, R. (2013) · International Journal of Cancer · doi:10.1002/ijc.28627 · Cited by 35
Screening for cervical cancer: when theory meets reality
Nygård, M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-240 · Cited by 34
Bryant, D. J., Tristram, A. J., Liloglou, T., Hibbitts, S. J., Fiander, A., & Powell, N. G. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.10.029 · Cited by 32
Catarino, R., Vassilakos, P., Stadali-Ullrich, H., Royannez, I., Guillot, C., & Petignat, P. (2014) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000051 · Cited by 29
Self-citationClinical Role of p16 INK4a Expression in Liquid-Based Cervical Cytology
Benevolo, M., Vocaturo, A., Mottolese, M., Mariani, L., Vocaturo, A., Marandino, F., Sperduti, I., Rollo, F., Antoniani, B., & Donnorso, R. P. (2008) · American Journal of Clinical Pathology · doi:10.1309/bepqxtcqd61rgfmj · Cited by 28
Cervical cancer in developing countries
Sankaranarayanan, R. (2002) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(02)90317-2 · Cited by 27
Dasari, S., Rajendra, W., & Valluru, L. (2014) · Medical Oncology · doi:10.1007/s12032-014-0139-9 · Cited by 26
Phillips, S., Garland, S. M., Tan, J., Quinn, M. A., & Tabrizi, S. N. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.11.017 · Cited by 25
Cervical cancer screening in Switzerland: time to rethink the guidelines
Vassilakos, P., Catarino, R., Tirri, B. F., & Petignat, P. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14112 · Cited by 15
Self-citation
Cited by
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Human papillomavirus and cervical cancer
Okunade, K. S. (2020) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1634030 · Cited by 809
“However, the development of rapid molecular methods for the detection of HPV DNA is a milestone in cervical cancer screening in these lowresource settings as these may make the test more feasible in the future and reduce the huge infrastructural requirements (Catarino et al. 2015).”
Ke, Y., Al Aboody, M. S., Alturaiki, W., Alsagaby, S. A., Alfaiz, F. A., Veeraraghavan, V. P., & Mickymaray, S. (2019) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2019.1614017 · Cited by 280
Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries
Lemp, J. M., De Neve, J.-W., Bussmann, H., Chen, S., Manne-Goehler, J., Theilmann, M., Marcus, M.-E., Ebert, C., Probst, C., Tsabedze-Sibanyoni, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.16244 · Cited by 190
Costa, S., Verberckmoes, B., Castle, P. E., & Arbyn, M. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02094-w · Cited by 139
Metadata
- Authors
- Catarino, R.
- Venue
- World Journal of Clinical Oncology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2015
- Volume
- 6
- Issue
- 6
- Pages
- 281
- ISSN
- 2218-4333 (ISSN-L)
- OpenAlex
- W2302752317
- Cited by
- 284
- References
- 83
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.